A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia

NCT01594983 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Familial Chylocmicronemia Syndrome (Non-FCS)

Interventions

DRUG: LCQ908
DRUG: Fenofibrate
DRUG: Fish Oil
DRUG: Placebo of LCQ908
DRUG: Placebo of fenofibrate
DRUG: Placebo of fish oil

Sponsor

Novartis Pharmaceuticals